Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954185 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-phospholipase C, delta 1 (PLCD1) (AA 154-184), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 154-184
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
The small GTPase Ral couples the angiotensin II type 1 receptor to the activation of phospholipase C-delta 1.
Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.
The small G protein Rac1 activates phospholipase Cdelta1 through phospholipase Cbeta2.
Saus E, Brunet A, Armengol L, Alonso P, Crespo JM, Fernández-Aranda F, Guitart M, Martín-Santos R, Menchón JM, Navinés R, Soria V, Torrens M, Urretavizcaya M, Vallès V, Gratacòs M, Estivill X
Journal of psychiatric research 2010 Oct;44(14):971-8
Journal of psychiatric research 2010 Oct;44(14):971-8
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
The small GTPase Ral couples the angiotensin II type 1 receptor to the activation of phospholipase C-delta 1.
Godin CM, Ferreira LT, Dale LB, Gros R, Cregan SP, Ferguson SS
Molecular pharmacology 2010 Mar;77(3):388-95
Molecular pharmacology 2010 Mar;77(3):388-95
Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.
Segat L, Brandão LA, Guimarães RL, Pontillo A, Athanasakis E, de Oliveira RM, Arraes LC, de Lima Filho JL, Crovella S
Vaccine 2010 Mar 2;28(10):2201-6
Vaccine 2010 Mar 2;28(10):2201-6
The small G protein Rac1 activates phospholipase Cdelta1 through phospholipase Cbeta2.
Guo Y, Golebiewska U, D'Amico S, Scarlata S
The Journal of biological chemistry 2010 Aug 6;285(32):24999-5008
The Journal of biological chemistry 2010 Aug 6;285(32):24999-5008
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB